Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Cipla has a robust governance model focused on sustainability
Subscribe To Our Newsletter & Stay Updated